Literature DB >> 12564722

Chronic intestinal inflammation and intestinal disease in dogs.

A J German1, E J Hall, M J Day.   

Abstract

Normal individuals maintain tolerance to the endogenous bacterial flora residing within their alimentary tract, a phenomenon mediated by the gastrointestinal lymphoid tissue. Loss of this tolerance is a key factor in the development of chronic intestinal inflammation. Manifestations of such uncontrolled inflammation in humans include inflammatory bowel disease and celiac disease. Dogs may similarly be affected, and although the etiopathogenesis is likely similar, the lesions differ. This review includes discussion of the factors involved in breakdown of mucosal tolerance, the immunologic basis of canine enteropathies, and the use of novel immunotherapies for these diseases.

Entities:  

Mesh:

Year:  2003        PMID: 12564722     DOI: 10.1892/0891-6640(2003)017<0008:ciiaid>2.3.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  44 in total

1.  Severe lymphocytic-plasmacytic and atrophic gastritis, as well as, predominantly eosinophilic, severe enteritis, in a 19-month-old Labrador retriever.

Authors:  Marjolaine Rousseau
Journal:  Can Vet J       Date:  2005-03       Impact factor: 1.008

Review 2.  Inflammatory bowel disease in the dog: differences and similarities with humans.

Authors:  Matteo Cerquetella; Andrea Spaterna; Fulvio Laus; Beniamino Tesei; Giacomo Rossi; Elisabetta Antonelli; Vincenzo Villanacci; Gabrio Bassotti
Journal:  World J Gastroenterol       Date:  2010-03-07       Impact factor: 5.742

3.  Alterations in Intestinal Permeability: The Role of the "Leaky Gut" in Health and Disease.

Authors:  Amy Stieler Stewart; Shannon Pratt-Phillips; Liara M Gonzalez
Journal:  J Equine Vet Sci       Date:  2017-03-07       Impact factor: 1.583

4.  Clinical characteristics of dogs presenting with vomiting as a gastrointestinal sign of chronic enteropathy.

Authors:  Rintaro Furukawa; Kaho Takahashi; Yuna Hara; Rinka Nishimura; Keiko Furuya; Tomoaki Shingaki; Hironari Osada; Hirotaka Kondo; Keitaro Ohmori
Journal:  Vet Anim Sci       Date:  2022-06-13

5.  Establishment and characterization of a primary canine duodenal epithelial cell culture.

Authors:  Julia L Golaz; Nathalie Vonlaufen; Andrew Hemphill; Iwan A Burgener
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-06-19       Impact factor: 2.416

6.  Utility of the combined use of 3 serologic markers in the diagnosis and monitoring of chronic enteropathies in dogs.

Authors:  Juan Estruch; Jacqueline Johnson; Sarah Ford; Sean Yoshimoto; Tracy Mills; Philip Bergman
Journal:  J Vet Intern Med       Date:  2021-05-07       Impact factor: 3.333

7.  Successful outcome after a single endoscopic fecal microbiota transplantation in a Shiba dog with non-responsive enteropathy during the treatment with chlorambucil.

Authors:  Koji Sugita; Ayaka Shima; Kaho Takahashi; Yasuyoshi Matsuda; Masaki Miyajima; Marin Hirokawa; Hirotaka Kondo; Junpei Kimura; Genki Ishihara; Keitaro Ohmori
Journal:  J Vet Med Sci       Date:  2021-04-26       Impact factor: 1.267

8.  Immunohistochemical investigation of Foxp3 expression in the intestine in healthy and diseased dogs.

Authors:  Johannes Junginger; Ulrike Schwittlick; Frederik Lemensieck; Ingo Nolte; Marion Hewicker-Trautwein
Journal:  Vet Res       Date:  2012-03-22       Impact factor: 3.683

9.  Mixtures of natural antimicrobials can reduce Campylobacter jejuni, Salmonella enterica and Clostridium perfringens infections and cellular inflammatory response in MDCK cells.

Authors:  Igori Balta; Adela Marcu; Nicolae Corcionivoschi; Mark Linton; Carmel Kelly; Ozan Gundogdu; Lavinia Stef; Ioan Pet; Patrick Ward; Myriam Deshaies; Todd Callaway; Phittawat Sopharat; Gratiela Gradisteanu-Pircalabioru
Journal:  Gut Pathog       Date:  2021-06-07       Impact factor: 4.181

10.  Prevalence of disorders recorded in dogs attending primary-care veterinary practices in England.

Authors:  Dan G O Neill; David B Church; Paul D McGreevy; Peter C Thomson; Dave C Brodbelt
Journal:  PLoS One       Date:  2014-03-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.